
Peer AI, a San Francisco, CA-based in a significant boost to the burgeoning field of AI-powered life sciences, Peer AI, a pioneering company dedicated to streamlining drug approvals, announced today it has successfully funded a $12.1 million. This substantial investment will accelerate the deployment and enhancement of its intelligent regulatory workflow platform, a solution poised to dramatically reduce the time and cost associated with bringing life-saving medications to market.
The Series A funding round was led by Flare Capital Partners and SignalFire. Other investors included Greycroft, Atria, Alumni Ventures, Gaingels,
Continue reading..